Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Bausch Health Companies Expects 2024 Revenues Of $9.4B-$9.65B Versus Prior Guidance Of $9.3B-$9.55B And Consensus Of $9.397B, With Adjusted EBITDA Of $3.21B-$3.36B Vs. Prior Guidance Of $3.20B-$3.35B

Author: Benzinga Newsdesk | August 01, 2024 07:21am

Posted In: BHC